Yu-hsin Lin
CEO at Belite Bio, Inc (BLTE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $20.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 2,635167,934 held (−2%) | $180.29 | $475K | -14.3% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 2,587165,347 held (−2%) | $181.24 | $469K | -14.8% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 3,413161,934 held (−2%) | $182.50 | $623K | -15.3% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 4,955156,979 held (−3%) | $183.30 | $908K | -15.7% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 6,252150,727 held (−4%) | $184.52 | $1.2M | -16.3% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 4,593146,134 held (−3%) | $185.34 | $851K | -16.6% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 7,800138,334 held (−5%) | $186.32 | $1.5M | -17.1% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 6,200132,134 held (−4%) | $187.25 | $1.2M | -17.5% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 3,045129,089 held (−2%) | $188.26 | $573K | -17.9% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 8,955120,134 held (−7%) | $189.34 | $1.7M | -18.4% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 600119,534 held (−0%) | $190.39 | $114K | -18.9% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 11,080108,454 held (−9%) | $191.15 | $2.1M | -19.2% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 4,209104,245 held (−4%) | $192.54 | $810K | -19.8% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 8,11196,134 held (−8%) | $193.13 | $1.6M | -20.0% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 2,40093,734 held (−2%) | $194.33 | $466K | -20.5% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 6,09087,644 held (−6%) | $195.62 | $1.2M | -21.0% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 6,05881,586 held (−7%) | $196.54 | $1.2M | -21.4% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 8,75272,834 held (−11%) | $197.36 | $1.7M | -21.7% |
| Sep 9SEC | BLTEBelite Bio, Inc | Sell Plan | 2,70070,134 held (−4%) | $198.09 | $535K | -22.0% |
| Aug 14SEC | BLTEBelite Bio, Inc | Sell Plan | 142170,792 held (−0%) | $180.00 | $26K | -14.2% |
| Aug 14SEC | BLTEBelite Bio, Inc | Sell Plan | 223170,569 held (−0%) | $180.57 | $40K | -14.4% |
| Apr 13SEC | BLTEBelite Bio, Inc | Sell Plan | 2,500177,634 held (−1%) | $180.36 | $451K | -14.3% |
| Apr 13SEC | BLTEBelite Bio, Inc | Sell Plan | 3,500174,134 held (−2%) | $181.33 | $635K | -14.8% |
| Apr 13SEC | BLTEBelite Bio, Inc | Sell Plan | 3,000171,134 held (−2%) | $182.40 | $547K | -15.3% |
| Apr 13SEC | BLTEBelite Bio, Inc | Sell Plan | 200170,934 held (−0%) | $183.00 | $37K | -15.6% |
- Sell
CEO Yu-hsin Lin sold $475K of BLTE at $180.29 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Yu-hsin Lin sold $469K of BLTE at $181.24 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Yu-hsin Lin sold $623K of BLTE at $182.50 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Yu-hsin Lin sold $908K of BLTE at $183.30 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Yu-hsin Lin sold $1.2M of BLTE at $184.52 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Yu-hsin Lin sold $851K of BLTE at $185.34 — pre-scheduled 10b5-1 plan sale.